Acute myeloid leukemia: Difference between revisions
Jump to navigation
Jump to search
| Line 52: | Line 52: | ||
* [http://www.leukemia-lymphoma.org/all_page?item_id=8459 Leukemia & Lymphoma Society page on Acute Myeloid Leukemia] | * [http://www.leukemia-lymphoma.org/all_page?item_id=8459 Leukemia & Lymphoma Society page on Acute Myeloid Leukemia] | ||
* [http://www.marrow.org National Marrow Donor Program] | * [http://www.marrow.org National Marrow Donor Program] | ||
* [http://www.cancer.gov/cancer_information/doc.aspx?viewid=4d3f920e-87d6-4b6a-a2fe-74c6efa53398&version=1 National Cancer Institute (NCI) PDQ statement on AML for health professionals] | * [http://www.cancer.gov/cancer_information/doc.aspx?viewid=4d3f920e-87d6-4b6a-a2fe-74c6efa53398&version=1 National Cancer Institute (NCI) PDQ statement on AML for health professionals] | ||
Revision as of 18:26, 22 August 2012
Template:DiseaseDisorder infobox
|
Acute myeloid leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute myeloid leukemia On the Web |
|
American Roentgen Ray Society Images of Acute myeloid leukemia |
|
Risk calculators and risk factors for Acute myeloid leukemia |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Synonyms and keywords: AML; acute granulocytic leukaemia; acute myeloblastic leukemia; acute myelogenous leukemia
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Acute myeloid leukemia from other Diseases
Epidemiology and demographics
Risk factors
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms | Physical Examination | Lab Tests | Chest X Ray | CT | Other Diagnostic Studies
Treatment
Medical therapy: Overview | Chemotherapy | Relapsed AML | Supportive Therapy
See also
External links
- American Cancer Society page on Acute Myeloid Leukemia
- Association of Cancer Online Resource (ACOR) Leukemia Links
- Leukemia & Lymphoma Society page on Acute Myeloid Leukemia
- National Marrow Donor Program
- National Cancer Institute (NCI) PDQ statement on AML for health professionals